| Prophylactic |
|
Sexually Transmitted Diseases (STDs) |
HIV |
|
The HIV epidemic has reached alarming proportions
worldwide. At least 15,000 new cases of AIDS emerge every
day in the world. In several African nations the epidemic
endangers the existence of an entire generation. Redox
Pharmaceutical Corporation has demonstrated an effective
microbicidal anti-HIV activity of Doxovir-M™ in vitro and
elucidated its mechanism of action on HIV revealing a mechanism
different from currently available pharmaceuticals. Pre-clinical development of
Doxovir-M™ is being pursued as an HIV prophylactic in preparation for
submission for an IND. |
|
|
Contact Us | Home
|
|
|
